Evans and Ellman
7.36-7.45 (m, 6H), 7.76-7.70 (m, 4H); 13C NMR (100 MHz) δ
10.4, 19.4, 20.5, 22.9, 26.5, 27.0, 55.8, 63.3, 77.8, 127.5, 127.7,
129.6, 129.8, 133.4, 134.0, 135.87, 135.91. anti-4b: [R]21D +2.75
Calcd for C19H35NO2SSi: C, 61.74; H, 9.54; N, 3.79. Found:
C, 61.56; H, 9.90; N, 3.77.
(RS,2S)-2-Meth yl-pr opan e-2-su lfin ic Acid (2-Ben zyloxy-
1-eth yl-p r op yl)-a m id e (6a ). The general procedure with
TMEDA was followed with use of 0.030 g (0.11 mmol) of 2a
and 0.035 mL (0.23 mmol, 2.1 eq) of TMEDA. Pure anti-6a
(0.029 g, 86% yield) was obtained as a clear oil after chroma-
tography (40% EtOAc/hexanes to 55% EtOAc/hexanes). HPLC-
MS (60-95% MeOH/H2O over 15 min at 0.5 mL/min) tR(anti-
6a ) ) 6.5 min, tR(syn-6a ) ) 8.2 min. syn-6a : 1H NMR (400
MHz) δ 0.94 (t, 3H, J ) 7.4), 1.20 (d, 3H, J ) 6.4), 1.21 (s,
9H), 1.73-1.79 (m, 2H), 2.97-3.05 (m, 1H), 4.47 (d, 1H, J )
10.0), 3.65 (dq, 1H, J ) 4.0, 6.4), 4.45 (d, 1H, J ) 11.2), 4.61
(d, 1H, J ) 11.6), 7.27-7.35 (m, 5H). anti-6a : IR 3035, 1555,
(c 4.14, CH2Cl2); IR 3041, 1591, 1469, 1108, 1055 cm-1 1H
;
NMR (400 MHz) δ 0.92 (t, 3H, J ) 7.2), 1.02 (d, 3H, J ) 6.4),
1.06 (s, 9H), 1.20 (s, 9H), 1.50-1.61 (m, 2H), 3.11-3.16 (m,
2H), 3.83 (dq, 1H, J ) 2.8, 6.4), 7.24-7.45 (m, 6H), 7.66-7.70
(m, 4H); 13C NMR (100 MHz) δ 10.7, 18.3, 19.2, 22.7, 25.0,
27.0, 55.9, 64.3, 72.0, 127.4, 127.6, 129.6, 129.7, 133.7, 134.2,
135.8, 135.9. Anal. Calcd for C25H39NO2SSi: C, 67.36; H, 8.82;
N, 3.14. Found: C, 67.17; H, 9.05; N, 3.06.
(SS,2S)-2-Meth yl-p r op a n e-2-su lfin ic Acid [2-(ter t-Bu -
tyl-d im eth yl-sila n yloxy)-1-eth yl-p r op yl]-a m id e (4c). The
general procedure was followed with use of 0.12 g (0.42 mmol)
of 1c. A mixture of syn- and anti-4c (0.13 g, 94% yield) was
obtained as a clear oil after chromatography (30% EtOAc/
hexanes to 40% EtOAc/hexanes). syn-4c: [R]21D +32.98 (c 4.85,
1
1472, 1066 cm-1; H NMR (400 MHz) δ 0.92 (t, 3H, J ) 7.2),
1.17 (d, 3H, J ) 7.2), 1.22 (s, 9H), 1.56 (apparent pent, 2H, J
) 7.2), 3.18 (dq, 1H, J ) 3.2, 7.2), 3.78 (d, 1H, J ) 7.2), 3.90-
3.95 (m, 1H), 4.52 (d, 1H, J ) 11.4), 4.56 (d, 1H, J ) 11.4),
7.26-7.35 (m, 5H); 13C NMR (100 MHz) δ 10.7, 15.4, 22.3, 22.6,
55.8, 61.1, 70.9, 77.4, 127.4, 127.8, 128.3, 138.6. Anal. Calcd
for C16H27NO2S: C, 64.60; H, 9.15; N, 4.71. Found: C, 64.39;
H, 9.32; N, 4.65.
1
CH2Cl2); IR 1074, 1053 cm-1; H NMR (400 MHz) δ 0.04 (s,
3H), 0.05 (s, 3H), 0.86-0.89 (m, 12H), 1.19-1.20 (m, 12H),
1.39-1.46 (m, 1H), 1.54-1.61 (m, 1H), 2.91-2.93 (m, 1H),
3.83-3.87 (m, 2H); 13C NMR (100 MHz) δ -4.2, -3.3, 10.3,
17.8, 20.7, 22.8, 25.7, 26.5, 55.7, 63.0, 69.5. Anal. Calcd for
C
15H35NO2SSi: C, 56.02; H, 10.97; N, 4.36. Found: C, 56.09;
(RS,2S)-2-Meth yl-p r op a n e-2-su lfin ic Acid [2-(ter t-Bu -
tyl-d ip h en yl-sila n yloxy)-1-eth yl-p r op yl]-a m id e (6b). The
general procedure with TMEDA was followed with use of 0.10
g (0. 24 mmol) of 2b and 0.075 mL (0.50 mmol, 2.1 equiv) of
TMEDA. Pure anti-6b (0.10 g, 93% yield) was obtained as a
clear oil after chromatography (25% EtOAc/hexanes to 35%
EtOAc/hexanes). HPLC-MS (60-95% MeOH/H2O over 20 min
at 0.4 mL/min) tR(anti-6b) ) 19.8 min, tR(syn-6b) ) 20.5 min.
H, 11.17; N, 4.42.
(RS,2S)-2-Meth yl-pr opan e-2-su lfin ic Acid (2-Ben zyloxy-
1-p h en yl-p r op yl)-a m id e (5a ). The general procedure with
TMEDA was followed with use of 0.020 g (0.075 mmol) of 2a
and 0.024 mL (0.16 mmol, 2.1 equiv) of TMEDA. Pure anti-
5a (0.021 g, 80% yield) was obtained as a clear oil after
chromatography (40% EtOAc/hexanes to 55% EtOAc/hexanes).
HPLC-MS (60-95% MeOH/H2O over 15 min at 0.5 mL/min)
anti-6b: [R]21 -53.38 (c 2.64, CH2Cl2); 1H NMR (400 MHz) δ
D
tR(syn-5a ) ) 10.3 min, tR(anti-5a ) ) 11.3 min. anti-5a : [R]21
0.79 (t, 3H, J ) 7.6), 0.95 (d, 3H, J ) 6.4), 1.06 (s, 9H), 1.24 (s,
9H), 1.37-1.44 (m, 1H), 1.66-1.75 (m, 1H), 3.07-3.15 (m, 1H),
3.91 (d, 1H, J ) 4.8), 4.13 (dq, 1H, J ) 3.2, 6.4), 7.35-7.44
(m, 6H), 7.68-7.70 (m, 4H); 13C NMR (100 MHz) δ 10.3, 17.6,
19.2, 22.7, 27.0, 33.6, 55.5, 61.5, 71.3, 127.5, 127.6, 129.6, 129.7,
D
-125.23 (c 2.30, CH2Cl2); IR 3278, 3031, 1603, 1494, 1068 cm-1
;
1H NMR (400 MHz) δ 1.05 (d, 3H, J ) 6.4), 1.27 (s, 9H), 3.86
(dq, 1H, J ) 4.0, 6.4), 4.11 (d, 1H, J ) 2.0), 4.59 (d, 1H, J )
11.6), 4.72 (d, 1H, J ) 11.6), 4.77 (dd, 1H, J ) 2.0, 4.0), 7.27-
7.41 (m, 10H); 13C NMR (100 MHz) δ 14.6, 22.6, 55.6, 59.3,
70.4, 77.7, 127.5, 127.7, 127.9, 128.1, 128.3, 128.4, 138.0, 138.3.
Anal. Calcd for C20H27NO2S: C, 69.53; H, 7.88; N, 4.05.
Found: C, 69.69; H, 8.04; N, 4.07.
133.2, 134.0, 135.76, 135.84. syn-6b : [R]21 -16.91 (c 5.21,
D
CH2Cl2); IR 3070, 1589, 1472, 1110, 1053 cm-1; 1H NMR (400
MHz) δ 0.86 (t, 3H, J ) 7.4), 1.05 (d, 3H, J ) 6.4), 1.17 (s,
9H), 1.20 (s, 9H), 1.61-1.68 (m, 1H), 1.77-1.85 (m, 1H), 2.86-
2.88 (m, 1H), 3.26 (d, 1H, J ) 8.4), 3.89 (dq, 1H, J ) 2.4, 6.4),
7.34-7.44 (m, 6H), 7.64-7.67 (m, 4H); 13C NMR (100 MHz) δ
10.8, 19.3, 19.8, 22.7, 26.0, 27.0, 56.1, 64.4, 70.2, 127.4, 127.7,
(RS,2S)-2-Meth yl-p r op a n e-2-su lfin ic Acid [2-(ter t-Bu -
tyl-diph en yl-silan yloxy)-1-ph en yl-pr opyl]-am ide (5b). The
general procedure with TMEDA was followed with use of 0.061
g (0.15 mmol) of 2b and 0.045 mL (0.30 mmol, 2.1 equiv) of
TMEDA. Pure anti-5b (0.052 g, 72% yield) was obtained as a
clear oil after chromatography (20% EtOAc/hexanes). syn-5b:
[R]21D -1.55 (c 1.80, CH2Cl2); 1H NMR (400 MHz) δ 0.97-0.98
(m, 12H), 1.24 (s, 9H), 4.22 (dq, 1H, J ) 2.8, 6.0), 4.32-4.33
(m, 2H), 7.25-7.43 (m, 13H), 7.61 (d, 2H, J ) 8.0). anti-5b:
[R]21D -90.82 (c 5.10, CH2Cl2); IR 3281, 3060, 1589, 1472, 1110,
1084 cm-1; 1H NMR (400 MHz) δ 0.92 (d, 3H, J ) 6.4), 1.12 (s,
9H), 1.31 (s, 9H), 4.05 (dq, 1H, J ) 4.0, 6.4), 4.24 (s, 1H), 4.46-
4.50 (m, 1H), 7.16 (d, 2H, J ) 7.6), 7.22-7.27 (m, 3H), 7.36-
7.49 (m, 6H), 7.66 (d, 2H, J ) 6.6), 7.70 (d, 2H, J ) 6.6); 13C
NMR (100 MHz) δ 16.9, 19.2, 22.7, 27.0, 55.5, 62.2, 72.9, 127.5,
127.6, 127.8, 128.0, 128.5, 129.7, 130.0, 133.0, 133.8, 135.8,
136.1, 138.1; HRMS calcd for C29H40NO2SSi 494.254904, found
494.254905.
129.6, 129.8, 133.2, 134.4, 135.7, 135.8; HRMS calcd for C29H40
NO2SSi 494.254904, found 494.254905.
-
(RS,2S)-2-Meth yl-p r op a n e-2-su lfin ic Acid [2-(ter t-Bu -
tyl-d im eth yl-sila n yloxy)-1-eth yl-p r op yl]-a m id e (6c). The
general procedure with TMEDA was followed with use of 0.15
g (0.52 mmol) of 2c and 0.16 mL (1.1 mmol, 2.1 equiv) of
TMEDA. Pure anti-6c (0.13 g, 81%) was obtained as a clear
oil after chromatography (30% EtOAc/hexanes to 40% EtOAc/
hexanes). HPLC-MS (60-95% MeOH/H2O over 25 min at 0.4
mL/min) tR(syn-6c) ) 19.5 min, tR(anti-6c) ) 20.4 min. syn-
6c: 1H NMR (400 MHz) δ 0.04 (s, 3H), 0.05 (s, 3H), 0.85 (s,
9H), 1.03 (t, 3H, J ) 6.0), 1.12 (d, 3H, J ) 6.0), 1.21 (s, 9H),
1.65-169 (m, 1H), 2.94-3.03 (m, 1H), 3.32 (d, 1H, J ) 7.2),
3.92 (dq, 1H, J ) 4.4, 6.0); 13C NMR (100 MHz) δ -4.9, -4.2,
10.9, 17.9, 20.7, 22.8, 25.8, 26.6, 56.3, 64.4, 68.7. anti-6c: [R]21
D
-35.92 (c 0.65, CH2Cl2); IR 1075 cm-1; H NMR (400 MHz) δ
1
(RS,2S)-2-Meth yl-p r op a n e-2-su lfin ic Acid [2-(ter t-Bu -
tyl-dim eth yl-silan yloxy)-1-ph en yl-pr opyl]-am ide (5c). The
general procedure with TMEDA was followed with use of 0.011
g (0.038 mmol) of 2c and 0.012 mL (0.077 mmol, 2.1 equiv) of
TMEDA. Pure anti-5c (0.011 g, 78% yield) was obtained as a
clear oil after chromatography (30% EtOAc/hexanes to 40%
EtOAc/hexanes). HPLC-MS (60-95% MeOH/H2O over 30 min
at 0.4 mL/min), tR(syn-5c) ) 22.7 min, tR(anti-5c) ) 23.3 min.
0.08 (s, 3H), 0.13 (s, 3H), 0.87 (s, 9H), 0.92 (t, 3H, J ) 7.2),
1.09 (d, 3H, J ) 6.4), 1.20 (s, 9H), 1.41-1.56 (br m, 2H), 3.02-
3.04 (m, 1H), 3.70 (d, 1H, J ) 7.2), 4.16 (dq, 1H, J ) 3.2, 6.4);
13C NMR (100 MHz) δ -4.7, -4.3, 10.7, 17.9, 19.2, 22.0, 22.8,
25.8, 55.8, 63.1, 70.8. Anal. Calcd for C15H35NO2SSi: C, 56.02;
H, 10.97; N, 4.36. Found: C, 55.89; H, 10.79; N, 4.48.
Gen er a l P r oced u r e for th e Ti En ola te Ad d ition to
N-ter t-Bu ta n esu lfin yl Ald im in es. A solution of i-Pr2NH
(2.20 equiv) in THF (0.70 M) was cooled to 0 °C. n-Butyllithium
(n-BuLi) (2.25 M, 2.10 equiv) was added via syringe and the
solution was stirred for 30 min. The solution was then cooled
to -78 °C and methyl acetate (2.00 equiv) was added via
syringe and the reaction solution was stirred for 30 min. To
anti-5c: [R]21 -82.56 (c 6.21, CH2Cl2); IR 3129, 1583, 1471,
D
1071 cm-1
;
1H NMR (400 MHz) δ 0.09 (s, 3H), 0.14 (s, 3H),
0.88 (s, 9H), 1.02 (d, 3H, J ) 6.0), 1.25 (s, 9H), 4.10 (dq, 1H,
J ) 4.0, 6.0), 4.13 (d, 1H, J ) 3.6), 4.45 (dd, 1H, J ) 3.6, 4.0),
7.25-7.33 (m, 5H); 13C NMR (100 MHz) δ -4.9, -4.5, 18.0,
22.6, 25.8, 55.6, 63.0, 71.9, 127.5, 128.1, 128.6, 138.4. Anal.
9954 J . Org. Chem., Vol. 68, No. 26, 2003